Insider Shareholders with Direct Ownership of Catalent, Inc. (CTLT)
This section provides a comprehensive overview of the insiders with direct ownership of Catalent, Inc. (CTLT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Catalent, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
John R Chiminski
Executive Chair |
697,536 | 771,613 | 229,888 $13.5 Million | 18 |
Aug 25, 2022
Reduced 14.48%
|
|
Alessandro Maselli
President & CEO |
184,572 | 24,914 | 177,521 $10.4 Million | 17 |
Jul 29, 2024
Reduced 4.87%
|
|
Aristippos Gennadios
Group Pres. Pharma & Consumer |
84,602 | 21,109 | 113,724 $6.68 Million | 22 |
Aug 02, 2024
Reduced 1.02%
|
|
John J Greisch
Executive Chair |
71,412 | 0 | 79,932 $4.69 Million | 4 |
Jul 26, 2024
Added 44.36%
|
|
Matti Masanovich
SVP, Chief Financial Officer |
79,468 | 2,993 | 76,475 $4.49 Million | 3 |
Jul 26, 2024
Added 35.78%
|
|
Steven L Fasman
EVP & Chief Admin Officer |
98,338 | 100,971 | 73,789 $4.33 Million | 23 |
Aug 24, 2023
Reduced 1.1%
|
|
Donald E Morel Jr
Director |
19,332 | 0 | 70,118 $4.12 Million | 5 |
Oct 30, 2024
Added 6.24%
|
|
Jonathan Arnold
SVP, CCO & Div. Head BioP Del. |
71,671 | 53,130 | 57,399 $3.37 Million | 20 |
Aug 24, 2023
Reduced 0.15%
|
|
Wetteny Joseph
SVP & Chief Financial Officer |
5,000 | 9,776 | 49,823 $2.93 Million | 4 |
Feb 16, 2021
Reduced 1.97%
|
|
Jack L Stahl
Director |
19,332 | 0 | 47,984 $2.82 Million | 5 |
Oct 30, 2024
Added 8.86%
|
|
Rolf A Classon
Director |
19,332 | 0 | 47,984 $2.82 Million | 5 |
Oct 30, 2024
Added 8.86%
|
|
Scott Gunther
SVP, Quality & Reg. Affairs |
42,905 | 21,360 | 39,635 $2.33 Million | 25 |
Aug 02, 2024
Reduced 1.65%
|
|
Lisa Evoli
SVP, Chief HR Officer |
15,338 | 3,859 | 39,366 $2.31 Million | 2 |
Aug 02, 2024
Reduced 8.93%
|
|
Gregory T Lucier
Director |
19,332 | 0 | 36,914 $2.17 Million | 5 |
Oct 30, 2024
Added 11.22%
|
|
David Mc Erlane
Group President, Biologics |
18,746 | 1,994 | 36,304 $2.13 Million | 2 |
Sep 26, 2024
Reduced 5.21%
|
|
J Martin Carroll
Director |
19,887 | 3,136 | 32,734 $1.92 Million | 7 |
Oct 30, 2024
Added 12.47%
|
|
Ricardo Pravda
Chief Transformation Officer |
30,281 | 11,756 | 30,224 $1.78 Million | 18 |
Aug 24, 2023
Reduced 1.24%
|
|
Ricky Hopson
Pres. BioProduct Delivery, CoS |
29,180 | 12,431 | 29,974 $1.76 Million | 23 |
Aug 02, 2024
Reduced 2.16%
|
|
Madhavan Balachandran
Director |
14,669 | 0 | 27,441 $1.61 Million | 4 |
Oct 27, 2023
Added 20.31%
|
|
Michael J Grippo
SVP, Strategy & Corp. Dev. |
23,489 | 17,546 | 24,449 $1.44 Million | 22 |
Aug 24, 2023
Reduced 1.57%
|
|
Karen Flynn
Director |
12,538 | 5,049 | 24,339 $1.43 Million | 7 |
Oct 27, 2023
Added 22.32%
|
|
Joseph Anthony Ferraro
SVP, General Counsel, CCO |
24,895 | 928 | 23,967 $1.41 Million | 5 |
Oct 18, 2024
Reduced 1.32%
|
|
Rosemary A Crane
Director |
14,669 | 0 | 23,873 $1.4 Million | 4 |
Oct 27, 2023
Added 22.66%
|
|
Thomas P Castellano
SVP, Chief Financial Officer |
14,248 | 6,716 | 20,099 $1.18 Million | 10 |
Aug 25, 2022
Reduced 6.57%
|
|
Christa Kreuzburg
Director |
14,669 | 3,026 | 18,283 $1.07 Million | 9 |
Jan 25, 2024
Reduced 2.78%
|
|
Michael J Barber
Director |
18,052 | 0 | 18,052 $1.06 Million | 5 |
Oct 30, 2024
Added 20.53%
|
|
Kay A Schmidt
SVP, Enterprise Functions |
8,729 | 10,090 | 17,388 $1.02 Million | 13 |
Aug 25, 2022
Reduced 7.06%
|
|
Manja Boerman
Pres. BioModalities Division |
6,676 | 5,522 | 14,414 $846,534 | 4 |
May 01, 2023
Reduced 9.12%
|
|
Michelle R Ryan
Director |
13,635 | 0 | 13,635 $800,783 | 4 |
Oct 30, 2024
Added 25.48%
|
|
Michael Hatzfeld
Chief Accounting Officer |
13,532 | 0 | 13,532 $794,734 | 2 |
Jul 26, 2024
Added 29.36%
|
|
Stephanie Okey
Director |
12,635 | 0 | 12,635 $742,053 | 3 |
Oct 30, 2024
Added 26.96%
|
|
Frank A Damelio
Director |
12,635 | 0 | 12,635 $742,053 | 3 |
Oct 30, 2024
Added 26.96%
|
|
Steven Barg
Director |
12,374 | 0 | 12,374 $726,725 | 3 |
Oct 30, 2024
Added 27.37%
|
|
Peter Zippelius
Director |
7,676 | 0 | 11,979 $703,526 | 3 |
Oct 27, 2022
Added 25.73%
|
|
Charles Lickfold
SVP, CIO |
5,959 | 325 | 11,339 $665,939 | 4 |
Aug 24, 2023
Reduced 1.65%
|
|
Patricia Hunt
Pres. Consumer Health Div |
3,190 | 628 | 11,267 $661,710 | 7 |
Oct 16, 2023
Reduced 0.19%
|
|
Lorenzo Carletti
SVP Global Ops Ph & Cons Hlth |
7,429 | 2,263 | 8,746 $513,652 | 8 |
Aug 24, 2023
Reduced 2.41%
|
|
Thomas W Hawkeswood
Pres. Pharma Prod Delivery Div |
3,827 | 2,006 | 7,533 $442,413 | 7 |
Aug 24, 2023
Reduced 1.91%
|
|
Michael A. Riley
Pres. Bio Product Delivery Div |
3,973 | 3,973 | 6,592 $387,148 | 3 |
Aug 26, 2022
Reduced 27.42%
|
|
Ricardo Zayas
SVP, Operations, Biologics NA |
4,435 | 0 | 6,223 $365,476 | 1 |
Aug 01, 2023
Added 41.61%
|
|
Mario Gargiulo
SVP, Ops, Biologics Europe |
4,269 | 3,351 | 5,676 $333,351 | 6 |
May 01, 2023
Reduced 10.67%
|
|
Karen Murphy Santiago
VP & Chief Accounting Officer |
4,763 | 0 | 4,763 $279,730 | 2 |
Aug 01, 2023
Added 32.96%
|
|
Ricci S Whitlow
President, CSS |
531 | 959 | 2,923 $171,667 | 4 |
Jan 21, 2022
Reduced 5.92%
|